Gladstone NOW: The Campaign Join Us on the Journey ✕
391 - 405 of 1428 Results Clear All
Gladstone scientists address the basics—and dispel misconceptions—about MPXV
Gladstone Experts MPXV Infectious Disease
Alex Marson, MD, PhD, director of the Gladstone-UCSF Institute of Genomic Immunology, comments on breakthrough technology developed in his lab that will greatly facilitate the large-scale engineering of immune cells for cell-based therapies.
Gladstone Experts Genomic Immunology Marson Lab CRISPR/Gene Editing
Scientists develop a new approach that produces enough cells for therapeutic applications
News Release Research (Publication) Genomic Immunology Esensten Lab Eyquem Lab Marson Lab CRISPR/Gene Editing
A Gene Not Previously Known to Regulate Immunity Could Turn Tired T-Cells Around
News Release Research (Publication) Cancer Genomic Immunology Carnevale Lab Marson Lab
In 2022, Gladstone’s Scientific Advisory Board met in San Francisco to review scientific programs and advise our researchers.
Office of the President Institutional News
Abdullah Syed, who is researching SARS-CoV-2, shares his passion for bad puns and animal facts, as well as his favorite part of working at Gladstone.
Postdoctoral and Graduate Student Education and Research Development Affairs Postdoc Advisory Committee Graduate Students and Postdocs Profile COVID-19 Doudna Lab
Wired—Measuring which genes are on and which are off in a cell usually requires killing it, meaning any measurement is simply a snapshot in time. Seth Shipman explains how his lab has circumvented this problem by re-engineering parts of a bacterial immune system to create a record of molecular events within a cell.
Gladstone Experts Data Science and Biotechnology Shipman Lab CRISPR/Gene Editing
Gladstone will provide comprehensive training to the biotech’s postdoctoral fellows
Graduate Students and Postdocs Institutional News
Brianne Dotson breaks down what unconscious bias is and how we can mitigate it in the workplace
People Services Diversity
Singularity Hub—Genomics tools allow scientists to get a glimpse of what genes are turned on in a cell at one particular moment, but understanding how genes are turned on or off over time, and in what order, has been impossible. Gladstone Investigator Seth Shipman has developed a biological recorder that keeps track of these events, offering a window into how cells change over time.
Gladstone Experts Data Science and Biotechnology Shipman Lab CRISPR/Gene Editing
Gladstone scientists engineer living biosensors to track the genetic activity of cells
News Release Research (Publication) Data Science and Biotechnology Shipman Lab
ABC7 News—The federal government plans to roll out a new vaccine against the BA.5 Omicron variant now predominant in the US early this fall. Senior Investigator Warner Greene, MD, PhD, says that you might want to hold off for your next booster shot until you can get this new vaccine, which will offer better protection against currently circulating variants.
Gladstone Experts COVID-19 Center for HIV Cure Research Infectious Disease Greene Lab
The Daily Californian—Senior Investigator Melanie Ott, MD, PhD, and collaborator Abdullah Syed, PhD, a postdoctoral fellow in the laboratory of Senior Investigator Jennifer Doudna, explain how they discovered that antibodies against early versions of the SARS-CoV-2 virus do not protect well against the now widespread and highly contagious Omicron variant, and recommend masking to avoid new infections.
Gladstone Experts COVID-19 Data Science and Biotechnology Infectious Disease Doudna Lab Ott Lab
Researchers used virus-like particles to identify which mutations of the Omicron SARS-CoV-2 virus make it more effective at infecting cells and escaping antibodies
News Release Research (Publication) COVID-19 Infectious Disease Doudna Lab Ott Lab
Gladstone researchers find new evidence against using BET inhibitors to treat COVID-19
News Release Research (Publication) COVID-19 Infectious Disease Ott Lab
